Association of direct oral anticoagulant–anticonvulsant coprescription with clinical outcomes in older adults: a population-based cohort study
Journal of Thrombosis and Haemostasis · 2026
DOI: 10.1016/j.jtha.2025.10.027 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Thrombosis and Haemostasis, 2026. Verfasst von Stephanie Carlin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Hamilton Health Sciences, Hamilton, Ontario, Canada; Division of Hematology and Thromboembolism, Department of Medicine, McMaster University, Hamilto…. Hauptthemen laut MEDLINE: Anticonvulsants, Thromboembolism, Factor Xa Inhibitors, Anticoagulants. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Institut canadien d'information sur la santé, AstraZeneca, Ontario Ministry of Health and Long-Term Care.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
BACKGROUND: Anticonvulsants vary in their theoretical propensity to interact with direct oral anticoagulants (DOACs). Coprescription may reduce DOAC efficacy and increase risk of thromboembolism. OBJECTIVES: To evaluate the risk of clinical outcomes - thromboembolism, major bleeding, and death - among patients who were receiving a DOAC and newly treated with an interacting anticonvulsant relative to those newly treated with a non-interacting anticonvulsant. METHODS: We undertook 3 cohort studies using administrative health care data for Ontarians aged ≥66 years who were using a DOAC and newly prescribed 1 of 3 groups of anticonvulsants with declining theoretic propensity for interaction: group 1 (strongly interacting); group 2 (mildly interacting); and group 3 (potentially interacting). Each cohort was compared with a reference group of patients who were newly coprescribed a DOAC with a presumed noninteracting anticonvulsant. The primary outcome was hospitalization for thromboembolism. Secondary outcomes were major bleeding, death, and a composite of thromboembolism or death. Analysis was by propensity score inverse probability of treatment weighted competing risk Fine-Gray regression models. RESULTS: We studied 17 325 patients: 878 in group 1; 313 in group 2; 943 in group 3; and 15 191 in the reference group. After inverse probability of treatment weighted, we did not observe an association with thromboembolism or major bleeding in groups 1 to 3. The Cox proportional hazards ratio for death in those prescribed group 1 anticonvulsants was 2.21 (95% CI, 1.77-2.75). CONCLUSION: In patients using a DOAC and newly prescribed a group 1, 2, or 3 anticonvulsant, we did not observe an increased risk of thromboembolism. In patients newly coprescribed a DOAC with a group 1 anticonvulsant, the observed increased risk of death is likely due to residual confounding.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hamilton Health Sciences, Hamilton, Ontario, Canada; Division of Hematology and Thromboembolism, Department of Medicine, McMaster University, Hamilton, Ontario, Canada; Population Health Research Institute, Hamilton, On…
- Division of Clinical Pharmacology and Toxicology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada; Clinical Pharmacology Research Group, Research Institute of St Joseph's Healthcare Hamilton, Hami…
- Department of Innovative Technologies in Medicine and Dentistry, "G. D'Annunzio" University, Chieti, Italy.
- ICES, Toronto, Ontario, Canada.
- ICES, Toronto, Ontario, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Department of Family Medicine, McMaster University, Hamilton, Ontario, Canada.
- Hamilton Health Sciences, Hamilton, Ontario, Canada; Division of Hematology and Thromboembolism, Department of Medicine, McMaster University, Hamilton, Ontario, Canada; St. Joseph's Healthcare Hamilton, Hamilton, Ontari…
Förderung
- Institut canadien d'information sur la santé
- AstraZeneca
- Ontario Ministry of Health and Long-Term Care
- Ministry of Long-Term Care
- Institute for Clinical Evaluative Sciences
Zitieren
APA
Carlin, S., Holbrook, A. M., Candeloro, M., Nguyen, F., Paterson, J. M., & Douketis, J. (2026). Association of direct oral anticoagulant–anticonvulsant coprescription with clinical outcomes in older adults: a population-based cohort study. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2025.10.027
Vancouver
Carlin S, Holbrook AM, Candeloro M, Nguyen F, Paterson JM, Douketis J. Association of direct oral anticoagulant–anticonvulsant coprescription with clinical outcomes in older adults: a population-based cohort study. Journal of Thrombosis and Haemostasis. 2026. doi:10.1016/j.jtha.2025.10.027
BibTeX
@article{Carlin2026,
author = {Carlin, Stephanie and Holbrook, Anne M and Candeloro, Matteo and Nguyen, Francis and Paterson, J Michael and Douketis, James},
title = {Association of direct oral anticoagulant–anticonvulsant coprescription with clinical outcomes in older adults: a population-based cohort study},
journal = {Journal of Thrombosis and Haemostasis},
year = {2026},
doi = {10.1016/j.jtha.2025.10.027}
}
EUVIMED